Beta-Blockers

Beta-blockers slow the heart on purpose — but they can also crash blood pressure, mask hypoglycemia, and trigger bronchospasm. Knowing which side effects demand action separates safe practice from a sentinel event.

Beta-blockers suppress sympathetic tone, which means every "fight-or-flight" response is blunted — and that's where the adverse effects live. Bradycardia and hypotension are the most common and most dangerous. Check apical pulse for 60 seconds and obtain BP before every dose; hold if HR is below 60 bpm or SBP is below 90 mmHg and notify the provider. Because beta-2 receptors control bronchodilation, non-selective agents (propranolol, carvedilol) can precipitate bronchospasm in patients with asthma or COPD. Fatigue, cold extremities, and sexual dysfunction are common quality-of-life complaints that affect adherence. In diabetic patients, beta-blockers mask tachycardia — the earliest sympathetic warning sign of hypoglycemia — so sweating is the most reliable remaining autonomic clue (neuroglycopenic signs such as confusion and irritability also persist). Abrupt discontinuation triggers rebound tachycardia and hypertensive crisis because receptor sites have upregulated during therapy. Always taper over 1–2 weeks. Teach the patient to rise slowly (orthostatic risk), monitor weight daily if prescribed for heart failure, and never stop the drug without provider guidance.

Key Distinctions

Don't confuse beta-blocker bradycardia (expected pharmacologic effect requiring dose-holding) with digoxin toxicity bradycardia (which also includes visual changes and GI symptoms). Students think beta-blockers eliminate all hypoglycemia symptoms — actually, they mask tachycardia specifically; sweating and tremor remain. Non-selective agents cause bronchospasm; cardioselective agents (metoprolol, atenolol) are safer for lung disease but are not risk-free at high doses.

Clinical Pearl

Beta-blockers hide the racing heart of low blood sugar. If your diabetic patient on a beta-blocker is sweating for no reason, check the glucose — tachycardia won't warn you.

MOA & Clinical Use

Beta-blockers work by competitively binding beta-adrenergic receptors, preventing catecholamines (epinephrine, norepinephrine) from activating the sympathetic fight-or-flight response. Beta-1 receptors live primarily in the heart. Blocking them decreases heart rate, contractility, and conduction velocity through the AV node — reducing myocardial oxygen demand. This is why beta-blockers are used for hypertension (especially with compelling indications such as post-MI or HFrEF), stable angina, heart failure with reduced ejection fraction, and rate control in atrial fibrillation. Beta-2 receptors live in the lungs and peripheral vasculature. Nonselective agents like propranolol block both beta-1 and beta-2; blocking beta-2 removes vasodilation (allowing unopposed alpha-1 vasoconstriction) and promotes bronchospasm — making them contraindicated in asthma and severe COPD. Cardioselective agents like metoprolol and atenolol preferentially block beta-1, sparing the lungs at lower doses. Carvedilol adds alpha-1 blockade, producing vasodilation on top of heart rate control — making it especially useful in heart failure. Critical nursing actions: hold for HR < 60 bpm or SBP < 90 mmHg, and never discontinue abruptly — rebound tachycardia and hypertensive crisis can result. The key clinical logic: beta-blockers reduce cardiac workload. Every approved indication traces back to that single mechanism.

Key Distinctions

Don't confuse cardioselective (metoprolol, atenolol — beta-1 only) with nonselective (propranolol — beta-1 and beta-2). Selectivity is dose-dependent; at high doses, even cardioselective agents lose their lung-sparing advantage. Students often confuse beta-blockers (which decrease heart rate and contractility) with calcium channel blockers like amlodipine (which primarily vasodilate with minimal heart rate effect). Verapamil and diltiazem overlap more closely but work through a different mechanism.

Clinical Pearl

Think "-olol" = slow and low. These drugs lower heart rate, lower blood pressure, and lower myocardial oxygen demand — every indication connects to that triad.